06

drip · policies · research tier

research use only.

effective · 2026-04-19

01

scope

products on drip are sold under one of two tiers: cosmetic and research. this policy applies only to items explicitly labeled research.

research-tier items are sold strictly for in-vitro research and laboratory use. they are not sold, marketed, or positioned for human ingestion, injection, inhalation, topical application, veterinary use, or any therapeutic purpose.

02

what you confirm at checkout

you are at least 18 years of age.

you are acquiring the item for bona-fide research or laboratory use.

you have verified that receipt, possession, and use of the item is lawful in your jurisdiction.

you will not resell, repackage, or re-label the item for human or veterinary use.

you accept that drip, the creator, and the manufacturer assume no liability for misuse.

03

claims language

research-tier product pages describe mechanism and published literature only. they do not make, and should not be read as making, claims to diagnose, treat, cure, mitigate, or prevent any disease.

statements referencing a compound's studied pathway are informational. they have not been evaluated by the fda, ema, or any regulatory agency.

04

jurisdiction + customs

regulatory status of research compounds varies by country, state, and province. buyers are responsible for verifying local legality before purchase.

we do not ship research-tier items to jurisdictions where their import is prohibited, to the extent we are aware of the prohibition. buyers in ambiguous jurisdictions purchase at their own risk.

seizures, duties, and holds at customs are the buyer's responsibility. we do not automatically refund for customs loss. damaged or lost shipments documented within 48 hours of delivery are reviewed case by case.

05

quality + batch records

research-tier items ship with a batch identifier tied to a hplc certificate of analysis. third-party analytical verification is available as a tier upgrade where offered by the creator.

coa availability does not constitute a medical, therapeutic, or safety endorsement. it confirms identity and purity of the supplied material only.

06

changes + contact

this policy evolves with platform rules and regulatory guidance. material changes are announced on this page with a new effective date.

questions: research@drip.markets.

effective: 2026-04-19.